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This study investigated the influence of genes and environ-ment on the variation of apolipoprotein and lipid levels,
which are important intermediate phenotypes in the pathways
toward cardiovascular disease. Heritability estimates are pre-
sented, including those for apolipoprotein E and AII levels
which have rarely been reported before. We studied twin
samples from the Netherlands (two cohorts; n = 160 pairs,
aged 13–22 and n = 204 pairs, aged 34–62), Australia 
(n = 1362 pairs, aged 28–92) and Sweden (n = 302 pairs, aged
42–88). The variation of apolipoprotein and lipid levels
depended largely on the influences of additive genetic factors
in each twin sample. There was no significant evidence for the
influence of common environment. No sex differences in 
heritability estimates for any phenotype in any of the samples
were observed. Heritabilities ranged from 0.48–0.87, with
most heritabilities exceeding 0.60. The heritability estimates in
the Dutch samples were significantly higher than in the
Australian sample. The heritabilities for the Swedish were
intermediate to the Dutch and the Australian samples and not
significantly different from the heritabilities in these other two
samples. Although sample specific effects are present, we
have shown that genes play a major role in determining the
variance of apolipoprotein and lipid levels in four independent
twin samples from three different countries.
Apolipoprotein and lipid profiles are important determi-
nants of cardiovascular risk (Rifai et al., 1988). Knowledge
of the environmental and genetic influences on these levels
is relevant for an understanding of the process of cardiovas-
cular disease. Genes described to date that promote
atherosclerosis have mainly been identified in familial syn-
dromes of lipid disorders, many of which are monogenic
diseases. For example, specific defects in the genes encoding
the low-density-lipoprotein-receptor and apolipoprotein B
are found to be responsible for the most common forms of
familial hypercholesterolemia (Hansen, 1998; Hobbs et al.,
1992; Ludwig et al., 1997). Furthermore, mutations in the
ABC1 gene, encoding the cholesterol efflux regulatory
protein, induce familial HDL cholesterol deficiency
(Brooks-Wilson et al., 1999). However, while these specific
mutations have a profound implication for persons with
monogenic familial syndromes, they explain only a minor
proportion of the population variation in serum
apolipoprotein and lipid levels (Goldstein et al., 1973).
Hence, it is relevant to estimate the importance of genetic
influences in the intermediate phenotypes in the general
population. Given significant genetic influences, efforts can
be undertaken to identify the genes influencing the varia-
tion of these intermediate phenotypes of cardiovascular
disease in the population.
In general the heritability, defined as the proportion of
the population variation attributable to genetic variation, of
total cholesterol, low-density-lipoprotein (LDL) choles-
terol, high-density-lipoprotein (HDL) cholesterol and
triglyceride levels is larger than 0.50. Genetic factors also
explained more than 50% of the total variance in
apolipoprotein AI and B. No obvious age trend in heritabil-
ity estimates could be detected and none of the previously
reported studies found much support for a considerable
influence of common environment on the variance of
apolipoprotein and lipid levels (Hamsten et al., 1986;
Snieder et al., 1999). Many previously reported heritability
studies on apolipoprotein and lipid levels focus mainly on
lipid levels and lack heritability estimates on apolipoprotein
E and AII levels.
In this paper we report the variance components attrib-
utable to intermediate phenotypes of cardiovascular disease,
including apolipoprotein E and AII levels, compared in
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four twin samples with different mean age and geographical
origin. We studied a young Dutch sample (aged 13–22) of
160 twin pairs (Boomsma et al., 1996) and a middle-aged
Dutch sample (aged 34–62) of 204 twin pairs (Snieder et
al., 1997). A Swedish twin sample (aged 42–88) provided
data on 146 twin pairs reared apart and 156 twin pairs
reared together (Heller et al., 1993). Heritability estimates
for some lipid and apolipoprotein levels have been reported
before for the Dutch and Swedish samples. This paper
reports for the first time on the heritability of apolipopro-
tein E level in the middle-aged Dutch sample. The largest
sample we studied was an Australian twin sample (aged
28–92) of 1362 twin pairs with data on apolipoprotein and
lipid levels, including apolipoprotein E and AII level.
Heritabilities for apolipoprotein and lipid levels in these
Australian twins have not been reported previously. Each
complete sample was investigated independently using the
same model in variance components analyses, testing
whether genes, common environment, unique environment
and sex have influences on the variation of apolipoprotein
and lipid levels.
Subjects and Methods
Subjects
Since different sampling methods have been used in the
Netherlands, Australia and Sweden all within different time
and age ranges, the subjects and methods used will be
described for each twin sample.
Young Dutch Twin Sample
The young Dutch twin sample is part of a larger study in
which cardiovascular risk factors were determined in ado-
lescent twin pairs and their parents (Boomsma et al.,
1993; Boomsma et al., 1996). The data reported here were
collected between 1988 and 1992 in a subgroup of 160
pairs of twins between 13 and 22 years of age. Addresses
of twins living in Amsterdam and neighbouring cities were
obtained from City Council population registries. Twins
still living with both their biological parents were con-
tacted by letter. A family was included in the study if the
twin and both parents were willing to comply. In addi-
tion, a small number of families who heard of the study
from other twins also volunteered to participate. Three
triplets were included by discarding the data of the
second-born subject. None of the twin pairs reported
taking lipid lowering medication.
Zygosity was determined by typing 11 blood group
polymorphisms. Zygosity in the dizygotic pairs was con-
firmed using 103 microsatellite markers on 10
chromosomes typed as part of a genome wide search
planned to comprise 229 markers. In total, there were 35
monozygotic male twin pairs (MZM), 31 dizygotic male
twin pairs (DZM), 35 monozygotic female twin pairs
(MZF), 30 dizygotic female twin pairs (DZF) and 29 dizy-
gotic twin pairs of opposite sex (DOS).
Middle-aged Dutch Twin Sample
The middle-aged Dutch twin sample is also part of the
larger study (Snieder et al., 1997). The data reported here
were collected between 1992 and 1996 in a group of 213
pairs of twins between 34 and 62 years of age. Twins were
recruited by a variety of means, including advertisement in
the media, advertisement in the information bulletin of
the Dutch Twin Registry and solicitation through the
Dutch Twin Club. In addition, a small number of twins
who heard of the study from other twins volunteered to
participate. One triplet was included by discarding the
data of the second-born subject. Data of 9 twin pairs were
excluded from the sample. In 8 of these twins one or both
members of the pair used lipid lowering medication
(HMG-CoA reductase inhibitors) and in one subject no
blood could be obtained.
Zygosity was decided on the basis of the response to
standard questions about physical similarity and the degree
to which others confused them. In 76 same-sex twin pairs
zygosity was also determined by DNA fingerprinting and
in 98.7% of those twin pairs zygosity was correctly classi-
fied. Zygosity of the dizygotic twin pairs was confirmed
using 103 microsatellite markers in a partial genome scan.
In total, there were 41 pairs of MZM, 35 pairs of DZM, 50
pairs of MZF, 40 pairs of DZF and 38 pairs of DOS.
Australian Twin Pair Sample
The Australian twin sample is part of the Semi-Structured
Assessment for the Genetics of Alcoholism study (Heath et
al., 1997). The data reported here were collected between
1993 and 1996 in a subgroup of 1403 pairs of twins
between 28 and 92 years of age. Twins were recruited
through the Australian NHMRC Twin Registry. Data of 41
twin pairs were excluded from the sample, since one or
both members of the pair used lipid lowering medication.
Zygosity was decided on the basis of the response to
standard questions about physical similarity and the
degree to which others confused them. Pairs giving incon-
sistent responses were contacted for clarification. In 329
same-sex twin pairs zygosity was also confirmed by typing
11 highly polymorphic markers and in 98.5% of those
twin pairs the zygosity was correctly classified. Of the
pairs who were classified as dizygotic, zygosity of 263 pairs
was confirmed using 103 microsatellite markers in a
partial genome scan. In total, there were 194 pairs MZM,
107 pairs of DZM, 517 pairs of MZF, 272 pairs of DZF
and 272 pairs of DOS.
Swedish Twin Pair Sample
The Swedish twin sample is part of the larger Swedish
Adoption/Twin Study of Aging sample (Pedersen et al.,
1984; Pedersen et al., 1991). The data reported here were
collected between 1986 and 1988 in a subgroup of 302
pairs of twins with the same sex between 42 and 88 years of
age. There are 146 twin pairs reared apart and 156 twin
pairs reared together included in this study. All the older
adults in this study reported not taking lipid lowering med-
ication. 
Zygosity was determined by typing serologic markers
(Pedersen et al., 1984). Of the dizygotic twins reared
together, zygosity of 44 twin pairs was confirmed using 103
microsatellite markers in a partial genome scan. In total,
there were 22 pairs of MZM reared apart, 31 pairs of DZM
reared apart, 24 pairs of MZF reared apart and 69 pairs of
DZF reared apart. In addition, there were 27 pairs of
88 Twin Research April 2002
Marian Beekman, et al.
MZM reared together, 38 pairs of DZM reared together,
42 pairs of MZF reared together and 49 pairs of DZF
reared together.
Method
Young Dutch Twin Sample
The subjects were requested to fast from 23:00 PM the pre-
ceding night. Blood was taken between 08:30 AM and
10:30 AM by venipuncture using Vacutainer tubes
(Becton-Dickinson) containing sodium-EDTA. The tubes
were placed on ice and centrifuged promptly (10 min,
3,000 rpm) at 4°C to separate plasma from the cells. Part of
plasma was kept on 4°C for lipid determination within the
next 5 days. The remainder was frozen using liquid nitro-
gen and stored at –20°C until processing.
Apolipoprotein E was quantified by enzyme-linked
immunosorbent assays (ELISA) (Bury et al., 1986).
Apolipoprotein AII, AI and B were quantified by radial
immunodiffusion as described by Albers (Albers et al.,
1976) and Havekes (Havekes et al., 1981).
Cholesterol and triglycerides were measured using enzy-
matic methods (Boehringer Mannheim, FRG, CHOD
_PAP kit number 236691 and GPO-PAP kit number
701904). High density lipoprotein (HDL) cholesterol was
measured after lipoproteins containing apolipoprotein B
were precipitated with phosphotungstate-magnesium chlo-
ride (Lopes-Virella et al., 1977).
Middle-aged Dutch Twin Sample
The subjects were requested to fast from 23:00 PM the pre-
ceding night. Blood was taken at about 10:00 AM by
venipuncture using Vacutainer tubes (Becton-Dickinson)
containing sodium-EDTA. The tubes were placed on ice
and centrifuged promptly (30 min, 2,000 g) at 4°C to sep-
arate plasma from the cells. Aliquots of plasma were frozen
using liquid nitrogen and stored at –20°C until processing.
Apolipoprotein E was quantified by enzyme-linked
immunosorbent assays (ELISA) (Jong et al., 1999).
Apolipoprotein AII plasma levels were quantified by radial
immunodiffusion as described by Albers (Albers et al.,
1976) and Zonderland (Zonderland et al., 1984).
The MZ twin correlation coefficients for apoAII level
were about 0.25 as compared to > 0.60 for all other phe-
notypes in this middle-aged Dutch twin sample. This
suggests a measurement problem and therefore, the
apolipoprotein AII levels in the middle-aged Dutch twins
were not analysed.
Apolipoprotein AI and B were quantified by the method
of Beckman using the Array Protein System (Beckman
Instruments) (Maciejko et al., 1987). The Beckman calibra-
tor (standardised to the International Federation for Clinical
Chemistry, which is traceable to the World Health
Organisation International Reference Material for ApoAI
and ApoB no. 1883) was used as standard reference mater-
ial. Monospecific goat-antihuman ApoAI and ApoB
antibodies were used (Beckman). Total cholesterol, trigly-
ceride and HDL cholesterol levels were determined in the
same way as for the young Dutch twin sample.
Australian Twin Sample
Blood was taken from the subjects throughout the day,
depending on their availability. The time since the last meal
was recorded. Aliquots of plasma were frozen and stored at
–70°C until analysis.
Plasma levels of apolipoprotein E, AII, AI, B and E
were quantified on a Behring nephelometer with Behring
reagents. Total cholesterol and triglyceride levels were mea-
sured on a Hitachi 747 analyser with Boehringer reagents
by standard enzymatic methods (Bucolo & David, 1973).
HDL cholesterol was measured after lipoproteins contain-
ing apolipoprotein B were precipitated with dextran
sulphate magnesium chloride (Warnick et al., 1982).
Swedish Twin Sample
The subjects were requested to fast for 12 hours before
blood was taken. Blood samples were frozen at –70°C,
transported in dry ice, and thawed and analysed when
received by the laboratory.
Apolipoprotein AI and B levels were quantified using
commercial radioimmunoassay kits (RIA 100, Pharmacia
Diagnostics, Uppsala, Sweden). Total cholesterol and triglyc-
eride levels were measured with an enzymatic colorimetric
assay (Boehringer Mannheim automated analysis for
Hitachi systems 717, Diagnostica, Mannheim, Germany).
HDL cholesterol was measured after lipoproteins containing
apolipoprotein B were precipitated with phosphotungstate-
magnesium chloride (Seigler & Wu, 1981).
In all samples, concentrations of low density lipopro-
tein (LDL) cholesterol were estimated according to
Friedewald (Friedewald et al., 1972), when triglyceride
concentrations did not exceed 4.52 mmol/L (Rifai et al.,
1992). LDL cholesterol level was considered missing, when
the triglyceride concentration did exceed 4.52 mmol/L,
which was the case for 1 individual of the middle-aged
Dutch sample, for 82 individuals of the Australian sample
and for 11 individuals of the Swedish sample.
Statistical Analyses
To study the contribution of genetic and environmental
factors to apolipoprotein and lipid levels variability, a
structural modelling approach was used. Univariate models
were fitted to the data by the method of maximum likeli-
hood. A univariate model was tested in which the
phenotypic variance is divided into an additive genetic, a
common environment (including family environment)
and a unique environment component. The additive
genetic component reflects the heritability of a trait and
the common environment reflects the shared-family envi-
ronment. Since the Swedish twin sample consists of twins
reared together and apart, an additional correlated envi-
ronment component, which may reflect, for example,
prenatal influence or post-rearing contact, was initially
present in the Swedish model. However, correlated envi-
ronment did not significantly influence the total variance
of any of the phenotypes and is therefore not shown in this
paper. Model fitting was carried out directly on the raw
data. This allows us to model the covariance structure
between family members simultaneously with any covari-
ate effects on the means. In all analyses, means were
adjusted for sex and age differences between pairs.
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To study sex differences in genetic influences, a model
with different parameter estimates for men and women for
additive genetic and both environmental components was
fitted to the data first, followed by a model in which para-
meter estimates for the different variance components were
constrained to be equal across sexes. We also fitted a sex
limitation scalar model, in which the heritabilities are con-
strained to be equal across sexes, but total variances are
allowed to be different; variance components for males are
constrained to be equal to a scalar multiple of the female
variance components. As a result, the standardised variance
components such as heritability are equal across sexes, even
though the non-standardised components differ (Neale &
Cardon, 1992).
The correlation between the additive genetic factors in
dizygotic twins of opposite sex was free to be estimated
between 0 and 0.5. When this correlation is estimated sig-
nificantly smaller than 0.5, different genes in men and
women influence the same phenotype, even though the
proportion of the variance attributed to genetic factors may
be the same.
By the principle of parsimony, the pattern of variances
and covariances should be explained by as few parameters
as possible. Therefore, the most extensive models were
reduced by excluding respectively the genetic or common
environmental component from the model for men and
women separately. When the best fitting model was the
same for men and women, common parameters were
equated between sexes. Sub-models were compared to the
most extensive model by hierarchic χ 2 tests. The difference
in –2ln(likelihood) of the goodness-of-fit of each model is
approximated by a chi-square distribution, with degrees of
freedom equal to the difference in number of parameters
estimated in the two models. A significant increase in the
–2ln(likelihood) after a parameter has been excluded from
the model indicates that the reduced model fits the data less
well than the most extensive model.
Because the distribution of the values for triglyceride
level was skewed in all samples, these values were trans-
formed by natural logarithm. All samples were analysed
separately. Model fitting was performed using Mx version
1.50 (Neale et al., 1999). Confidence intervals around stan-
dardised variance components (e.g. heritabilities) were also
obtained from Mx.
Results
Descriptives
Table 1 shows means and standard deviations for levels of
apolipoprotein E and AII, levels of other apolipoproteins
and lipids in each sample for men and women separately.
In all samples women had higher HDL cholesterol and
apolipoprotein AI levels than men. Middle-aged Dutch
and Australian men had higher mean values than middle-
aged Dutch and Australian women for LDL cholesterol,
apolipoprotein B and triglyceride level. In younger Dutch
and older Swedish subjects this sex difference seemed to
be absent.
Twin Correlation Coefficients
Twin correlation coefficients for the traits for each twin
sample are shown by zygosity groups for men and women
in table 2a–d. Correlation coefficients for apolipoprotein E
levels were available in the Dutch young and middle-aged
twins and in the Australian sample. In monozygotic (MZ)
twins the correlations for apolipoprotein E levels were
higher than in dizygotic (DZ) twins, which is a strong indi-
cation that genetic factors influence these levels.
Correlation coefficients for apolipoprotein AII levels were
only available in the young Dutch and Australian twin
sample, and these correlations also suggested the influence
of genetic factors. This was also the case for the other
apolipoprotein and lipid levels.
In the young Dutch twin pairs (Table 2a), the correla-
tion coefficients for total cholesterol and LDL cholesterol
in DZ men, but not in women, are relatively low. However,
it is unlikely that this low correlation reflects an error in the
LDL cholesterol measurements of the young Dutch DZ
men, since the phenotypic measurements were performed
randomly over the young Dutch sample.
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Table 1
Descriptives of the Twin Samples, Means (and Standard Deviations) for Each Sample by Sex, for Levels of Apolipoprotein E, AII, AI and B 
and for Levels of Total, Low-density-lipoprotein, High-density-lipoprotein Cholesterol and the Natural Log of Triglyceride Levels
Twin sample Young Dutch twins Middle-aged Dutch twins Australian twins Swedish twins
Mean (SD) Men Women Men Women Men Women Men Women
Number of individuals 161 159 192 218 874 1850 234 350
Age (yr) 16.77 (1.78) 16.71 (2.20) 43.55 (6.47) 44.70 (6.79) 44.10 (10.41) 45.88 (11.69) 65.02 (7.51) 66.09 (8.99)
Apolipoprotein E (mg/dL) 6.03 (2.06) 7.58 (2.42) 2.50 (1.08) 2.57 (0.97) 4.28 (1.89) 3.87 (1.62) — — — —
Apolipoprotein AII (g/L) 0.58 (0.07) 0.58 (0.08) — — — — 0.35 (0.06) 0.36 (0.07) — — — —
Apolipoprotein AI (g/L) 1.34 (0.15) 1.44 (0.23) 1.50 (0.35) 1.93 (0.38) 1.32 (0.22) 1.51 (0.29) 1.27 (0.24) 1.48 (0.28)
Apolipoprotein B (g/L) 0.78 (0.15) 0.80 (0.19) 1.27 (0.34) 1.19 (0.34) 1.05 (0.25) 0.94 (0.25) 1.07 (0.21) 1.12 (0.26)
Total cholesterol (mmol/L) 4.05 (0.65) 4.47 (0.86) 5.39 (1.03) 5.46 (1.04) 5.71 (1.05) 5.60 (1.08) 6.35 (1.10) 7.20 (1.46)
LDL cholesterol (mmol/L) 2.52 (0.63) 2.76 (0.76) 3.71 (0.97) 3.60 (0.97) 3.55 (0.91) 3.37 (0.99) 4.28 (1.01) 4.87 (1.30)
HDL cholesterol (mmol/L) 1.23 (0.22) 1.38 (0.29) 1.07 (0.29) 1.39 (0.33) 1.23 (0.29) 1.56 (0.39) 1.32 (0.36) 1.60 (0.44)
Ln(Triglycerides) (mmol/L) –0.49 (0.39) –0.41 (0.36) 0.16 (0.52) –0.04 (0.40) 0.62 (0.59) 0.29 (0.54) 0.40 (0.51) 0.35 (0.46)
The MZ correlations in the middle-aged Dutch twins
(Table 2b) are higher than the DZ correlations for all pheno-
types, indicating that genetic factors influence these traits.
In the Australian sample (Table 2c), the correlation coef-
ficients in DZ twins of opposite sex for apolipoprotein B,
total cholesterol, LDL, HDL and triglyceride level seem to be
lower than the correlation coefficients of DZ twins of the
same sex. This may indicate that different genes affect these
traits in men and women.
In the Swedish men (Table 2d), the DZ correlations 
are more than twice as low as the MZ correlations, 
which could indicate that dominant genetic factors might
influence these traits.
Structural Modelling
Figure 1 shows the proportion of the variances estimated
under the conditions of the most extensive model, includ-
ing a separate additive genetic, common and unique
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Table 2a
Twin Correlation Coefficients in the Young Dutch Twin Sample
Young Dutch twins
Sex Men Women DOS
Zygosity (number of pairs) MZ (35) DZ (31) MZ (35) DZ (30) DOS (29)
ApoE 0.87 0.38 0.86 0.17 0.41
ApoAII 0.90 0.46 0.81 0.60 0.30
ApoAI 0.86 0.34 0.77 0.50 0.53
ApoB 0.83 0.55 0.82 0.60 0.71
Total cholesterol 0.90 0.11 0.81 0.63 0.41
LDL cholesterol 0.89 0.22 0.83 0.56 0.44
HDL cholesterol 0.73 0.48 0.81 0.47 0.57
Triglycerides 0.59 0.59 0.71 0.32 0.17
Table 2b
Twin Correlation Coefficients in the Middle-aged Dutch Twin Sample
Middle-aged Dutch twins
Sex Men Women DOS
Zygosity (number of pairs) MZ (42) DZ (35) MZ (50) DZ (40) DOS (38)
ApoE 0.82 0.48 0.92 0.35 0.46
ApoAII — — — — —
ApoAI 0.73 0.56 0.67 0.49 0.47
ApoB 0.80 0.67 0.78 0.30 0.35
Total cholesterol 0.75 0.55 0.79 0.41 0.46
LDL cholesterol 0.77 0.65 0.80 0.27 0.37
HDL cholesterol 0.61 0.34 0.70 0.37 0.17
Triglycerides 0.62 0.47 0.60 0.40 0.43
Table 2c
Twin Correlation Coefficients in the Australian Twin Sample
Australian twins
Sex Men Women DOS
Zygosity (number of pairs) MZ (194) DZ (107) MZ (517) DZ (272) DOS (272)
ApoE 0.51 0.17 0.65 0.33 0.28
ApoAII 0.54 0.17 0.44 0.24 0.23
ApoAI 0.34 0.22 0.56 0.22 0.18
ApoB 0.61 0.48 0.68 0.39 0.28
Total cholesterol 0.63 0.41 0.60 0.43 0.22
LDL cholesterol 0.61 0.39 0.63 0.44 0.22
HDL cholesterol 0.57 0.41 0.64 0.29 0.22
Triglycerides 0.52 0.40 0.55 0.41 0.25
environmental variance component for men and women in
each sample. In the Australian sample, genetic factors
explain 46–60% of the variance of apolipoprotein E levels
and in the Dutch young and middle-aged samples
85–89%. Common environment explains at most 4% of
the total variance of apolipoprotein E level.
Under the full model, genetic factors explain 36–40%
of the total variance of apolipoprotein AII level in women
and 58–84% in men. Common environment may play a
larger role in women than in men. The proportions of the
variance explained by common environment are, respec-
tively, 0.10–0.35 and 0.0–0.02, under the full model.
For apolipoprotein AI and B levels, 21–70% of the
variance is determined by genetic influences and 0–48% of
the variance can be explained by common environment.
Between 21–85% of the variance of lipid levels is deter-
mined by genetic factors and 0–43% by common
environmental factors.
Overall, genetic factors seem to play a larger role than
common environment in explaining inter-individual differ-
ences in levels of apolipoproteins and lipids.
After fitting the most extensive model, sub-models were
compared to the full model by hierarchic χ 2 tests to find a
model to explain the data that is as simple as possible. A
model in which the variance was only explained by common
and unique environment showed in all analyses a significant
worse fit than the full model. A model in which the variance
was only influenced by a genetic and a unique environmen-
tal factor (AE model) did not show a significantly worse fit
than the full model in any of the analyses. Therefore,
common environment does not play a significant role in
determining the levels of apolipoproteins and lipids in any
of the samples. In table 3, the genetic variance versus the
total variance is listed for men and women separately. Also
the heritability estimates and the 95% confidence interval
for all traits are listed for the most parsimonious models sep-
arately in each sample. All heritabilities were equal across
sexes in every sample. In some analyses the scalar model was
the best fitting model (Table 3, indicated with b), in which
the proportion of the variance attributable to genetic factors
is equal across sexes, even though the non-standardised esti-
mates for the genetic effect differ.
Since samples are all collected at different times and
centres and since the measurements on these samples were
all at different laboratories using slightly different
methods, it is not surprising that absolute values of the
variances differ over the samples. Unfortunately, we are
unable to tell which of these factors is responsible for the
differences in variance components, but the 95% confi-
dence intervals of the heritability permit comparisons
between the four samples.
The heritability estimates for apolipoprotein E level
range from 0.57 in the Australian sample to 0.87 in the
middle-aged Dutch sample. The heritability estimates in
the Dutch samples are significantly higher than the esti-
mate in the Australian sample. Also the heritability
estimates for apolipoprotein AII level in Australian sample
(0.48) is significantly lower than in the young Dutch
sample (0.82).
For apolipoprotein AI and B levels, the heritability
ranges from 0.50 in the Australian twins to 0.82 in young
Dutch twins. The heritability estimates in the Swedish
sample lie between the estimates for the Dutch and
Australian samples, which differ significantly from each
other. Common environment seems not to play a signifi-
cant role in the total variance of apolipoprotein AI levels in
all the samples. However, its role in the variance of
apolipoprotein B levels is unclear. In the young Dutch and
Australian twins, models including additive genetic as wel
as common environment variance had fits that were almost
significantly better than the AE model (Table 3; indicated
with a). However, in the middle-aged Dutch and Swedish
samples, there is no suggestion that common environment
might play a role in the inter-individual differences of
apolipoprotein B levels.
The heritability estimates for lipid levels ranged from
0.48 for triglyceride level in the Swedish sample to 0.83 for
LDL cholesterol level in young Dutch twins. In the
Australian and Swedish samples, common environment
might play a role in the variance of total cholesterol levels,
since the models including additive genetic as well as
common environmental variance almost fitted better than
the simpler models. However, in the Dutch samples no sug-
gestion was found for the influence of common environment
on the total cholesterol levels. Furthermore, the models
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Table 2d
Twin Correlation Coefficients in the Swedish Twin Sample
Swedish twins
Sex Men Women DOS
Zygosity (number of pairs) MZ (49) DZ (69) MZ (66) DZ (118) DOS
ApoE — — — — —
ApoAII — — — — —
ApoAI 0.70 0.15 0.57 0.31 —
ApoB 0.60 0.16 0.77 0.39 —
Total cholesterol 0.54 0.11 0.61 0.41 —
LDL cholesterol 0.53 0.20 0.56 0.42 —
HDL cholesterol 0.71 0.21 0.61 0.32 —
Triglycerides 0.42 0.15 0.63 0.34 —
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Figure 1 
Proportions of variance that can be explained by influence of genes, common environment and unique environment. These proportions 
are estimated using the full model for each sample estimating parameters for males and females separately.
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including common environment for the Australian LDL
cholesterol and triglyceride levels also nearly fitted better
than AE models, although no indications for common envi-
ronmental influences were observed in the other samples.
In general, the four twin samples show high heritability
estimates for all apolipoprotein and lipid levels without sex
differences. The effect of common environment on the
variances was not significant in any of the samples. No sig-
nificant difference has been observed between the
heritability estimates of the two Dutch samples. The young
Dutch twins show significantly higher estimates for
apolipoprotein AI and LDL cholesterol levels than the
Swedish twins do; while in the middle-aged Dutch twins
none of the heritability estimates significantly differ from
the estimates in the Swedish twins. Roughly, there seems no
difference between the Dutch and Swedish twins in heri-
tability estimates, although the Swedish estimates are
consistently lower.
The most striking differences in heritability are those
between the Dutch and the Australian samples, that would
have to be explained by sample specific differences. The
heritability estimates in the Dutch twin cohorts are signifi-
cantly higher than in the Australian twins, except for HDL
cholesterol and triglyceride levels.
Analysing the Australian sample for total and LDL chol-
esterol, models in which the correlations between the
additive genetic factors of DZ twins of opposite sex were
fixed to 0.5 like in DZ twins of same sex, fitted signifi-
cantly worse than the models in which these correlations
were free to be estimated. The correlation coefficient
between the additive genetic factors of DZ twins of opposite
sex was then estimated to 0.26 (Table 3, indicated with c).
Hence, only half of the genes influencing total and LDL
cholesterol levels are acting in both Australian men and
women indicating that the other half of the genes are sex
specific. However, this was not found in the two Dutch
samples that are much smaller than the Australian sample
and therefore have less power to detect sex-specific genetic
effects. The DOS correlations in the Dutch samples,
however, do not suggest such an effect. Since no twins of
opposite sex were present in the Swedish twin pair sample,
no conclusions can be drawn from this sample.
When the correlation in DZ twins was less than half of
the correlation in MZ twins, models including a domi-
nance genetic factor were examined. However, none 
of these models fitted significantly better than the model
which only included an additive genetic and unique 
environmental factor.
Discussion
In this paper, data from three different countries were
analysed to obtain heritabilities for intermediate pheno-
types of cardiovascular disease. We found that 48 to 87%
of the total variances is attributable to genetic factors. The
two Dutch samples showed the highest heritabilities
ranging from 0.62 to 0.87. The Swedish heritabilities
ranged from 0.48 to 0.75 and the Australian heritabilities
ranged from 0.48 to 0.63. The differences in heritability
estimates between the Dutch samples and the Australian
sample were significant. We did not find evidence for
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influences of common environment on the variance of any
apolipoprotein or lipid level in any of the samples. No sex
differences in heritability estimates were observed in any of
the twin samples.
The total variance of apolipoprotein E levels depended
largely on genetic influences. We have previously reported
heritability of apolipoprotein E levels in the young Dutch
twin sample (Boomsma et al., 1996). These results are now
supplied with heritability estimates in the middle-aged
Dutch twins of 0.87 and in the Australian twins of 0.57,
which augments the role of genetic factors in determining
the level of apolipoprotein E. Also a large part of the vari-
ance of apolipoprotein AII levels can be explained by
genetic factors, although there are sample specific differ-
ences in the heritability estimates. The heritability estimate
in the young Dutch twins was 0.82 and in the Australian
twins 0.48. Our findings are in line with the few previously
reported studies (Berg, 1984; Hasstedt et al., 1984;
Sistonen & Ehnholm, 1980).
We found high heritabilities for apolipoprotein AI
levels in all samples ranging from 0.50 in the Australian
twins to 0.80 in the young Dutch twins. Heritability esti-
mates for levels of apolipoprotein AI previously gave
contradicting results. Some studies found no evidence for
additive genetic influences (Sistonen & Ehnholm, 1980;
Hasstedt et al., 1984) and others found heritabilities of
comparable magnitude (Berg, 1984) as we report in this
paper for the four samples.
The total variance of apolipoprotein B levels in young
Dutch, middle-aged Dutch, Australian and Swedish twins
is for 63 to 82% attributable to additive genetic influences.
This corresponds to previous findings reviewed by Snieder
(Snieder et al., 1999). Since the influences of common
environment are almost significantly present in young
Dutch and middle-aged Australian twins (Table 3, indi-
cated with a), it may well be that these influences play a role
in apolipoprotein B levels. However, Boomsma (Boomsma
et al., 1996) showed that when the young Dutch twin
sample was extended with parental data, the most parsimo-
nious model on the apolipoprotein B levels was the model
only including additive genetic and unique environmental
factors. And since in the other twin samples no evidence
was found for influences of common environment, we con-
clude that the common environment does not play a large
role in the variation of apolipoprotein B levels.
Furthermore, the heritability estimates for total cholesterol,
LDL, HDL and triglyceride levels ranged from 0.48 to
0.87 without sex differences, which is in correspondence
with previously reported heritabilities (Snieder et al., 1999). 
In the Australian sample, models for total and LDL
cholesterol levels, in which the correlation between the
additive genetic factors of DZ twins of opposite sex were
fixed to 0.5, fitted significantly worse than the models in
which this correlation was free to be estimated. Hence, only
half of the genes influencing total and LDL cholesterol
levels are acting in both Australian men and women. This
could not be confirmed in the two Dutch samples, possibly
due to lack of power. Since no twins of opposite sex were
present in the Swedish twin pair sample, no conclusions
can be made from this sample. From a biological point of
view, it seems not very likely that only in the Australian
sample different genetic influences act in men and women.
It may be, however, that Australian women are exposed to
higher levels of hormonal treatment than Dutch women are
(Shelley et al., 1995; Barentsen, 1996) that explains part of
the variance in their LDL levels (Crook & Seed, 1990) and
that part of the response to these hormones is genetically
determined (Birley et al., 1997). Since no other study
reported such genetic sex differences, we are cautious in
drawing a firm conclusion.
From our data can be concluded that none of the lipid
traits studied in this paper is significantly influenced by
common environment. In literature, contradicting results
are found in relation to common environmental factors
(Rice et al., 1991; Vogler et al., 1989; Hunt et al., 1989;
Ellison et al., 1999). However, since our twin samples are
quite large, especially the Australian sample including 1362
twin pairs, it seems unlikely that we have lack of power in
this study to obtain significance.
We have shown that large parts of the variances of
intermediate phenotypes of cardiovascular disease can be
explained by genetic factors. A number of candidate genes
are known to influence some of these traits. For example, it
is known that the APOE ε2/ε3/ε4 polymorphism influ-
ences apolipoprotein E levels (Reilly et al., 1991; Neale et
al., 2000). Additionally, the T allele of the –219GT APOE
promoter polymorphism is independently associated with
lower levels of apolipoprotein E (Lambert et al., 2000).
However, only approximately 20% of the genetic variance
can be explained by known polymorphisms at the APOE
locus. None of the heritabilities reported can be totally
explained by known polymorphisms in candidate genes.
In this study design, the influence of age on heritability
is difficult to assess. Each sample was collected in a differ-
ent time period and the apolipoprotein and lipid
measurements were performed in different laboratories. It is
impossible to distinguish between age and geographical
origin of the samples. Age effects in the Dutch twin
samples have been analysed by Snieder (Snieder et al.,
1997) using the data on parents of young twins in addition
to the data on twins themselves. It appeared that at differ-
ent ages partly different genes influence the variance of
levels of triglycerides, total, LDL, and HDL cholesterol.
But age had no effect on the heritability of intermediate
phenotypes of cardiovascular disease in the Dutch samples.
Assuming that age does not influence the heritabilities
leads us to conclude that the significant differences between
the Dutch and the Australian samples are caused by sample
specific factors. Each sample is drawn from populations
which are likely to differ in their genetic as well as environ-
mental makeup. The larger influence of environmental
factors in the Australian sample might be a genuine effect,
explained either by a larger main effect of environment on
lipid levels or by an interaction with genetic factors (Birley
et al., 1997). Furthermore, the measurements are performed
with slightly different methods and in different laboratories,
which could result in different measurement errors, which
are included in the unique environmental factors. Increases
in unique environmental estimates would lead to concomi-
tant decreases in estimates of genetic factors.
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In conclusion, we have shown that apolipoprotein E
and AII levels show high heritabilities in four independent
samples, comparable with other intermediate phenotypes of
cardiovascular disease. Common environment does not
influence the variances and there are no sex differences in
the heritabilities of these intermediate phenotypes. Given
the high heritabilities observed, these four twin cohorts
would provide a unique sample for QTL mapping of the
genes involved.
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